Fucus vesiculosus / Phyllitis scolopendrium comp. Gocce per uso orale

Land: Schweiz

Sprache: Italienisch

Quelle: Swissmedic (Swiss Agency for Therapeutic Products)

Wirkstoff:

adonis vernalis (HAB) D3, alchemilla vulgaris (HAB) D2, arnica montana (HAB) D3, carbo vegetabilis (HAB) D6, fucus vesiculosus (HAB) D2, hyssopus officinalis e herba rec. D2 (HAB 3a), nasturtium officinale (HAB) D2, phyllitis scolopendrium e herba rec. D2 (HAB 3a), phytolacca americana (HAB) D4

Verfügbar ab:

Regena AG

INN (Internationale Bezeichnung):

adonis vernalis (HAB) D3, alchemilla vulgaris (HAB) D2, arnica montana (HAB) D3, carbo vegetabilis (HAB) D6, fucus vesiculosus (HAB) D2, hyssopus officinalis e herba rec. D2 (HAB 3a), nasturtium officinale (HAB) D2, phyllitis scolopendrium e herba rec. D2 (HAB 3a), phytolacca americana (HAB) D4

Darreichungsform:

Gocce per uso orale

Zusammensetzung:

adonis vernalis (HAB) D3 0.11 ml, alchemilla vulgaris (HAB) D2 0.11 ml, arnica montana (HAB) D3 0.11 ml, carbo vegetabilis (HAB) D6 0.11 ml, fucus vesiculosus (HAB) D2 0.11 ml, hyssopus officinalis e herba rec. D2 (HAB 3a) 0.11 ml, nasturtium officinale (HAB) D2 0.11 ml, phyllitis scolopendrium e herba rec. D2 (HAB 3a) 0.11 ml, phytolacca americana (HAB) D4 0.11 ml, aqua purificata, ethanolum 96 per centum 0.39 g, ad solutionem pro 1 ml, corresp. 47 guttae, corresp. ethanolum 49 % V/V.

Klasse:

D

Therapiegruppe:

Farmaci Omeopatici

Therapiebereich:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

Berechtigungsstatus:

zugelassen

Berechtigungsdatum:

2011-03-31